Screener
Artiva Biotherapeutics, Inc. ARTV Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Artiva Biotherapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338029
FAQ
- What is Artiva Biotherapeutics, Inc.'s debt-to-equity?
- Artiva Biotherapeutics, Inc. (ARTV) reported debt-to-equity of 0× in Q2 2026.
- How has Artiva Biotherapeutics, Inc.'s debt-to-equity changed year-over-year?
- Artiva Biotherapeutics, Inc.'s debt-to-equity decreased by 68.1% year-over-year, from 0.1× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Artiva Biotherapeutics, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude